Ascendis Pharma A-S
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $173,916 | $57,833 | $35,998 | $35,998 |
Gross Profit | 159,893 | 46,632 | 24,533 | 24,533 |
EBITDA | -37,893 | -71,129 | -87,510 | |
EBIT | -42,368 | -72,831 | -89,527 | |
Net Income | -38,469 | -99,198 | -109,380 | -109,380 |
Net Change In Cash | 173,916 | 57,833 | 35,998 | 35,998 |
Free Cash Flow | -87,559 | -61,650 | ||
Cash | 559,543 | 625,515 | 258,696 | 258,696 |
Basic Shares | 57,345 | 59,760 | 57,349 | 57,345 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $363,641 | $266,718 | $51,174 | $7,778 |
Gross Profit | 319,383 | 222,323 | 39,037 | 4,255 |
EBITDA | -290,023 | -411,168 | -556,040 | -423,668 |
EBIT | -307,737 | -430,079 | -573,674 | -439,672 |
Net Income | -378,084 | -481,447 | -583,194 | -383,577 |
Net Change In Cash | 363,641 | 266,718 | 51,174 | 7,778 |
Free Cash Flow | -307,624 | -469,803 | -510,188 | -441,883 |
Cash | 559,543 | 392,164 | 444,767 | 446,267 |
Basic Shares | 57,345 | 56,287 | 56,071 | 54,771 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.64 |
2024-09-30 | -$1.72 |
2024-06-30 | -$2.11 |
2024-03-31 | -$2.30 |
